Autopsy report · NCT00774241

PRIMADOS Study:A Study of Avastin (Bevacizumab) Plus Docetaxel for First Line Treatment of Patients With Metastatic Breast Cancer

Cause of deathOther Automatic label, confidence 0.3, unverified. How labels are made.

“Study was put on hold then out of Medical Plan therefore cancelled”

The sponsor’s own words in the registry.

Life of this trial

Withdrawn before it enrolled anyone. Its dates are the sponsor's plans, not events that happened.

Vital statistics

Status: Withdrawn
Phase: Phase 4
Sponsor: Hoffmann-La Roche
Sponsor type: Industry
Conditions: Breast Cancer
Interventions: bevacizumab [Avastin]; docetaxel
Participants: 0

Look deeper

The official registry record (the source of truth)
Record history: every change the sponsor made
Open it in the database

Everything here comes from the current ClinicalTrials.gov record. The timeline uses the record’s dates; dates marked planned are the sponsor’s plans. The cause of death is an automatic, unverified label. This is research information, not medical advice.